CNABIS – II Congress of Medicinal Cannabis, is an online and free event that aims to present cannabis and its therapeutic applications as an alternative for the treatment of various health conditions. This, which is the second edition of the event, will take place from August 3rd to 5th, 2021. Organized by the medical platform Dr. Cannabis, the congress is aimed at doctors, health professionals and medical students, but it is open to all and all who want to learn more about the topic. Registration is free and is already open at this link.
The II Congress of Medicinal Cannabis will feature the participation of great names in research and clinical practice in Brazil and the world, who will address issues ranging from the history of the plant, through the pharmacology of its derivatives to the therapeutic effects of cannabis and its role in sport, treatment of pathologies and health, in addition to unraveling myths related to use.
“When the topic is medical cannabis, we have a much greater challenge than the scientific one, which is access to information. Therefore, we invite iconic scientists and physicians to share their experience and discoveries with the Brazilian medical public. Our expectation is to bring together specialists and those interested in the subject to foster debate, share experiences and innovations and clarify doubts and myths about the use of cannabis”, comments Viviane Sedola, CEO and founder of Dr. Cannabis.
Among the confirmed speakers at the Medicinal Cannabis Congress are well-known names, such as neuroscientist, biologist and writer Sidarta Ribeiro; Dr. Mário Grieco, Specialist in Clinical Medicine Fellowship in Family Medicine in the USA; Dr. Stephen M. Dahmer, certified family physician and member of the Arizona Center for Integrative Medicine; Dr. Verônica Christine de Paiva, prescriber of treatments based on Medicinal Cannabis, with 15 years of experience in outpatient and urgent/emergency clinical care; between others. The full list of speakers can be found here.
The Medical Cannabis Congress will last for three days, two of which are open to the public and one day with exclusive content for doctors, where topics and information that will facilitate the application of cannabinoid therapy in Brazil will be addressed.
Participants can register and attend all lectures for free over the three-day event. Anyone who wants to have access to the content for another six months can purchase Premium Access, which allows them to study the topic in greater depth. In addition, when purchasing Premium Access, the participant earns a certificate of participation in the Medical Cannabis Congress with proof of hours.
This year, the Dr. Cannabis platform also launches another novelty aimed at training physicians in the application of cannabinoid therapy. The medical training course Cannabis Medicinal do Zero it has renowned professors and fundamental tools to help physicians with the decision of whether or not to prescribe cannabinoids, with the prescription itself, as well as with the follow-up and monitoring of patients being treated with cannabis products.
In 2020, the first edition of CNABIS had more than 16 thousand participants from all Brazilian states and from more than 20 countries. The congress promoted a qualified debate on what is currently known about the relationship between cannabis use and autism, chronic pain, Parkinson’s disease, anxiety, epilepsy, Covid-19, use in the elderly, regulation in Brazil, among other topics.
Secure your seat at CNABIS – II Congress of Medicinal Cannabis.